Cape Town plant to scale down production
Low demand for Covid-19 jabs
About 100 million doses a year are slated to be packaged and filled at a plant controlled by the BioVac Institute.
Plans to produce Pfizer Covid-19 vaccine in Cape Town may be scaled back because of waning demand for the shots, according to the head of the company’s South African manufacturin
...
As jy n aktiewe intekenaar is en die artikel wys nie, meld asseblief af en weer aan. Gratis toegang tot artikels vanaf 12:00.
Kommentaar
Republikein
Geen kommentaar is op hierdie artikel gelaat nie